ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

48,379Medicare Part D Prescriptions Filled, Including Refills

Rank: 4 out of 5176

$3.59M Total Retail Price of All Prescriptions

Rank: 5 out of 5176

1,085 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
90% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

1% of this provider’s 1,085 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

4% of this provider’s 1,085 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

2% of this provider’s 37,776 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

43% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$74 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

45 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
SIMVASTATIN 2,316 1,847 1 1
OMEPRAZOLE 1,974 1,502 2 3
METFORMIN HCL 1,206 921 3 7
AMLODIPINE BESYLATE 1,180 965 4 2
NEXIUM 1,169 861 5 16
LOVAZA 1,013 693 6 43
LEVOTHYROXINE SODIUM 949 795 7 4
CRESTOR 837 654 8 15
FUROSEMIDE 821 716 9 8
DIOVAN 733 634 10 19
SINGULAIR 728 571 11 62
LOSARTAN POTASSIUM 710 513 12 14
METOPROLOL TARTRATE 698 570 13 6
METOPROLOL SUCCINATE 662 569 14 11
ZOLPIDEM TARTRATE 656 514 15 17
TRAMADOL HCL-ACETAMINOPHEN 635 507 16 116
CLOPIDOGREL 622 542 17 26
ZETIA 607 464 18 68
DICLOFENAC SODIUM 604 455 19 160
ALENDRONATE SODIUM 588 443 20 18
ADVAIR DISKUS 570 405 21 32
IBUPROFEN 535 334 22 72
ALCOHOL SWABS 528 388 10 23 115
PLAVIX 509 450 24 29
DIOVAN HCT 497 328 25 39
RAMIPRIL 491 402 26 50
GLIMEPIRIDE 491 339 26 37
HYDROCHLOROTHIAZIDE 485 353 28 10
CARVEDILOL 476 425 29 24
NAPROXEN 448 306 30 95
LISINOPRIL 444 349 31 5
ATORVASTATIN CALCIUM 416 351 32 9
ATENOLOL 409 334 33 12
NAMENDA 404 396 34 47
CLOTRIMAZOLE-BETAMETHASONE 388 304 35 94
JANUVIA 381 326 36 25
DONEPEZIL HCL 377 360 37 28
MECLIZINE HCL 372 291 38 81
ENALAPRIL MALEATE 371 260 39 22
JANUMET 367 239 40 77
MELOXICAM 356 236 41 53
MONTELUKAST SODIUM 355 283 42 123
FAMOTIDINE 338 296 43 58
VOLTAREN 324 276 44 97
VENTOLIN HFA 316 216 45 64
LOSARTAN-HYDROCHLOROTHIAZIDE 314 257 46 35
AMMONIUM LACTATE 297 228 47 91
GABAPENTIN 292 214 48 21
CELEBREX 284 231 49 80
AMLODIPINE BESYLATE-BENAZEPRIL 280 213 50 55
DOXAZOSIN MESYLATE 278 255 51 103
TAMSULOSIN HCL 278 259 51 20
FLUOCINONIDE 276 227 53 165
PROAIR HFA 273 202 54 60
FINASTERIDE 254 224 55 69
GLYBURIDE-METFORMIN HCL 254 232 R 55 76
ACTOS 241 161 57 85
SPIRIVA 241 188 57 54
GLYBURIDE 240 184 R 59 67
NIFEDIPINE ER 229 219 60 48
ATELVIA 223 176 61 146
MICARDIS 216 171 62 154
RANITIDINE HCL 213 155 63 36
SERTRALINE HCL 211 140 64 30
LACLOTION 208 171 10 65 299
FENOFIBRATE 201 128 66 102
LANTUS 201 117 66 66
TRAMADOL HCL 182 110 68 40
FLUTICASONE PROPIONATE 179 153 69 38
MICARDIS HCT 178 119 70 180
LANSOPRAZOLE 176 145 71 113
PRAVASTATIN SODIUM 175 120 72 23
SYMBICORT 175 154 72 120
AMITIZA 168 127 74 197
KOMBIGLYZE XR 165 106 75 291
GLIPIZIDE 164 144 76 63
LIDODERM 162 141 77 59
ALLOPURINOL 152 121 78 41
LIPITOR 144 121 79 51
METFORMIN HCL ER 144 103 79 57
LANTUS SOLOSTAR 134 91 81 70
WARFARIN SODIUM 134 134 81 13
CYCLOBENZAPRINE HCL 133 44 R 83 143
SOLARAZE 133 119 83 157
NITROSTAT 130 115 85 205
WELCHOL 130 77 85 230
INSULIN SYRINGE 127 89 87 137
DILTIAZEM 24HR CD 126 114 88 119
AZITHROMYCIN 125 101 89 42
ESCITALOPRAM OXALATE 124 81 90 89
TRICOR 123 85 91 148
DEXILANT 122 104 92 118
HYDROCODONE-ACETAMINOPHEN 120 64 S3 93 27
ISOSORBIDE MONONITRATE ER 120 111 93 44
FOSINOPRIL SODIUM 116 99 95 105
EXELON 116 92 95 162
PROMETHAZINE HCL 115 81 R 97 221
LYRICA 115 99 97 133
HYDROXYZINE HCL 115 88 R 97 213
CIPROFLOXACIN HCL 113 95 100 84
QUINAPRIL HCL 112 96 101 82
LACTULOSE 110 87 102 87
PANTOPRAZOLE SODIUM 110 94 102 61
SYNTHROID 108 70 104 33
IBANDRONATE SODIUM 99 90 105 211
GLIPIZIDE XL 98 89 106 83
PIOGLITAZONE HCL 95 70 R 107 237
CYMBALTA 95 49 107 90
CARBIDOPA-LEVODOPA 94 93 109 98
BONIVA 89 84 110 236
PRADAXA 89 89 110 192
AVODART 87 64 112 107
EXFORGE 86 81 113 126
PATADAY 85 66 114 220
VYTORIN 85 81 114 152
DOXEPIN HCL 83 63 116 354
RISPERIDONE 83 67 116 78
BUMETANIDE 81 41 118 209
PEN NEEDLE 80 41 119 144
LABETALOL HCL 80 65 119 114
LEVEMIR FLEXPEN 79 58 121 200
CITALOPRAM HBR 76 45 122 31
RIVASTIGMINE 76 75 122 364
SPIRONOLACTONE 76 72 122 88
PATANOL 76 61 122 158
DIGOXIN 75 75 126 56
BYSTOLIC 73 58 127 96
MIRTAZAPINE 73 37 127 45
BENICAR 72 68 129 100
SELEGILINE HCL 70 70 130 485
TORSEMIDE 65 55 131 184
AMIODARONE HCL 64 64 132 281
PAROXETINE HCL 64 37 132 93
AGGRENOX 61 54 134 235
MOMETASONE FUROATE 60 53 135 251
ATENOLOL-CHLORTHALIDONE 59 56 136 161
LEXAPRO 59 33 136 193
HALOPERIDOL 58 58 138 145
UNIFINE PENTIPS 58 42 138 261
CILOSTAZOL 58 58 138 206
ZOVIRAX 56 40 141 313
FLOVENT HFA 56 42 141 203
AMOX TR-POTASSIUM CLAVULANATE 55 44 143 141
SUCRALFATE 54 36 144 303
PROLIA 54 39 144 448
BISOPROLOL-HYDROCHLOROTHIAZIDE 53 43 146 164
LUNESTA 53 29 146 242
LEVETIRACETAM 52 27 148 92
VERAPAMIL ER 52 30 148 155
LISINOPRIL-HYDROCHLOROTHIAZIDE 52 38 148 49
NYSTATIN-TRIAMCINOLONE 51 32 151 142
AMITRIPTYLINE HCL 50 41 R 152 177
POLYETHYLENE GLYCOL 3350 50 44 152 74
VESICARE 50 48 152 210
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 25, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.